Choosing a cellular model to study SARS-CoV-2
2022
Gabriel Augusto Pires De Souza | Gabriel Augusto Pires De Souza | Marion Le Bideau | Marion Le Bideau | Céline Boschi | Céline Boschi | Nathalie Wurtz | Nathalie Wurtz | Philippe Colson | Philippe Colson | Sarah Aherfi | Sarah Aherfi | Christian Devaux | Christian Devaux | Christian Devaux | Bernard La Scola | Bernard La Scola
As new pathogens emerge, new challenges must be faced. This is no different in infectious disease research, where identifying the best tools available in laboratories to conduct an investigation can, at least initially, be particularly complicated. However, in the context of an emerging virus, such as SARS-CoV-2, which was recently detected in China and has become a global threat to healthcare systems, developing models of infection and pathogenesis is urgently required. Cell-based approaches are crucial to understanding coronavirus infection biology, growth kinetics, and tropism. Usually, laboratory cell lines are the first line in experimental models to study viral pathogenicity and perform assays aimed at screening antiviral compounds which are efficient at blocking the replication of emerging viruses, saving time and resources, reducing the use of experimental animals. However, determining the ideal cell type can be challenging, especially when several researchers have to adapt their studies to specific requirements. This review strives to guide scientists who are venturing into studying SARS-CoV-2 and help them choose the right cellular models. It revisits basic concepts of virology and presents the currently available in vitro models, their advantages and disadvantages, and the known consequences of each choice.
显示更多 [+] 显示较少 [-]